Why did SPL rise 13.4% on 16 Mar 2026?
Starpharma · Pharmaceuticals, Biotechnology & Life Sciences
What moved it
Insufficient news evidence to explain the abnormal price move.
The provided news articles around the event date do not mention Starpharma Holdings or any specific event that would directly drive its stock price. The articles are generic market commentary or about unrelated companies, providing no link to SPL.AX's 13.41% jump. Without any company-specific news, the cause cannot be identified from the available information.
Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice.
The evidence
In the news
Why Nanosonics (ASX:NAN) Is Executing a $20M Buy-Back
Kalkine · 16 Mar 2026
2 ASX small-cap shares with 100% potential upside
The Motley Fool Australia · 13 Mar 2026
Weekly Wrap: Shares fall another 2.6% for the week as conflict worsens
smallcaps.com.au · 13 Mar 2026
Headlines link to the publisher.
Held by no ETF
Not currently held by any ETF we track.